Large-scale testing (Phase 3)Study completedNCT01277042
What this trial is testing
Study to Assess Immune Responses and Safety of the GSK-580299 Vaccine in Healthy Women (26 to 45 Years)
Who this might be right for
Infections, Papillomavirus
GlaxoSmithKline 1,212